Genmab — Oktober 2017
-
Som EL postede forleden: Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.http://www.biopharminternational.com/jj-invests-biologic-manufacturing-capacity-expansion-ireland-0
-
Var lige ved at supplere i 1358-59 da den gik op...spændende eller det modsatte hvilken retning den skal i morgen???
-
-
Michael Friis: https://play.borsen.dk/social/59e5c67b45628ff817210276
-
Det er vel en klassiker med den slags negative reaktioner i selskaber, hvor markedet har høje vækstforventninger.
-
Som så umiddelbart ikke indfries. Det kan så eventuelt ske i Q4 - og alle er glade igen.
-
Bortset fra det har jeg svært ved at forstå, at SH tallet fra september skal være som meget lavere end august.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind